Memory Machine drives into town to promote brain health awareness on Oct. 6

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida take Alzheimer’s Disease clinical research on the road

By Staff | Oct 4, 2023

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida will be driving clinical research into the community as they introduce the Memory Machine to Fort Myers. The new Memory Machine will allow the research teams to provide education about brain health at mobile site stops throughout the region. Members of the Alzheimer’s Disease clinical research teams will be on site to introduce the new mobile unit to the communities and provide informational resources.

In Florida, it is estimated that more than 580,000 people are currently living with Alzheimer’s Disease, and experts predict that this number will increase to almost 750,000 people by 2025.

“With the diagnosis of Alzheimer’s Disease on the rise, Neuropsychiatric Research Center of Southwest Florida is raising awareness through the new mobile Memory Machine, which will be out for display on Friday, Oct. 6,” said Amy Schenk, RN, BSN, MS Ed. of Neuropsychiatric Research Center of Southwest Florida. “We are committed to continue our efforts to end Alzheimer’s Disease through early detection and research, and this van will help us take our site on the road to meet people where they are.”

With World Smile Day falling on Friday, Oct. 6, the Memory Machine will be unveiled at Neuropsychiatric Research Center of Southwest Florida with coffee and morning snacks available to help the Fort Myers community smile as they begin their day.

Memory Machine Kickoff Event

Oct. 6 from 7:30 to 11 a.m.

Neuropsychiatric Research Center of SW Florida

14271 Metropolis Ave., Fort Myers

Brain Matters Research and Neuropsychiatric Research Center of Southwest Florida are part of the Global Alzheimer’s Platform Foundation network of clinical trial sites, GAP-Net, which is a network of academic and private research sites dedicated to advancing clinical research for Alzheimer’s and other neurodegenerative diseases.

To top